WPA LOGO
October 2012
Pharmacopsychiatry

Pharmacopsychiatry 

The WPA Section on Pharmacopsychiatry was very productive in the past years and published altogether five position papers that were published in the European Archives of Psychiatry and Clinical Neurosciences as well as in Schizophrenia Research

Under the leadership of the past Section Chair, Prof. Hans-Jürgen Möller, these papers covered up-to-date topics like “Do SSRIs or antidepressants in general increase suicidality”, “Comparative effectiveness of antipsychotics in the treatment of schizophrenia”, “Comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders” as well as “The efficacy of pharmacotherapy in bipolar disorders”.  

From 2012 onwards, the Section on Pharmacopsychiatry has a new leadership with Prof. Siegfried Kasper (Austria) as Chair as well as Prof. Pierre Blier (Canada) as Co-chair who will continue the work on treatment of relevant questions, focusing on polypharmacy as well as on the topic of how and when to stop psychotropic medication. We do welcome relevant suggestions for treatment as well as diagnostics by the Section as well as by WPA members.

Siegfried Kasper   

 

Chair, WPA Section on Pharmacopsychiatry

« Back
Send this to a colleague